Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

The objective this paper is to examine the rate of 7-day follow-up after an OUD-related ED visit and the association with future overdoses.

Original research | 2022
Hospitals, Wrap-around services, About PWUD, Overdose

Due to the high potency of illicitly manufactured fentanyl (IMF), multiple naloxone administrations (MNA) may be needed per overdose event.

Original research | 2022
Overdose, Harm reduction

This study explores the role of police interactions in responding to PWUD within the broader institutional and structural contexts in which they operate.

Original research | 2022
Legal system/law enforcement, Policy/Regulatory, Social services, Poverty, Mental health

People who use methamphetamine concurrently with opioids face an elevated risk of harm.

Original research | 2022
Harm reduction, About PWUD, Equity, Stimulants
Page Web | 2020
la politique / le cadre de réglementation
Webpage | 2020
Policy/Regulatory

The study sought to identify indicators of success in primary care–based medication for OUD (MOUD) treatment from the perspectives of patients with OUD and the physicians who treat them.

Original research | 2022
About PWUD, About prescribers, Transitions in care/treatment, Substitution/OAT, Stigma

We investigated the association between OAT engagement and providing injection drug use (IDU) initiation assistance across poly-drug use practices in Vancouver, Canada.

Original research | 2022
About PWUD, Outcomes, Illegal drugs, Injecting drugs

This paper proposes a stigma-vulnerability nexus as a critical incursion into understandings of and responses to drug-related social problems.

Original research | 2022
Stigma, Policy/Regulatory, Equity

BZDs are often a difficult drug class to cease once neuroadaptation has occurred; recommendations usually involve gradual dose reductions of variable rates.

Original research | 2022
Withdrawal, Clinical guidance
Manuel | 2020
la réduction des méfaits, les services enveloppants, à propos des prescripteurs, les services sociaux, les drogues illégales, les stimulants, s'injecter les drogues
Video | 2022
Drug checking, Illegal drugs, Harm reduction
Guidelines | 2022
Clinical guidance, About prescribers, Injecting drugs

Underutilized regulations allow non-Opioid Treatment Program (OTP) providers to administer methadone for opioid withdrawal for up to 72 hours while arranging ongoing care.

Original research | 2022
Hospitals, Transitions in care/treatment, Substitution/OAT

As supervised consumption services (SCS) are scaled-up across Canada, information on those who require help injecting is necessary to inform equitable service uptake.

Original research | 2022
Equity, About PWUD, Illegal drugs, Sex/Gender , SCS/OPS

The objective was to employ latent class analysis (LCA) to empirically categorize and extract potential typologies of poly-substance users within a multi-site cohort of illicit opioid and other dru

Original research | 2009
About PWUD, Illegal drugs

Affiner votre recherche

Mots clés
Format
Région